The stock falls after investors get a peek at the royalty-rate structure that pharma giant Roche will pay if a promising new cancer drug is approved.
The pharma's earnings may not look great, but bailing out could prove costly for investors if its Alzheimer's drug is successful.
If you aren't in 1 of these 3 areas, you are playing an earnings-and-macro game that rides more on luck than skill.
Apple initiated with 'neutral,' and Netflix downgraded to 'underperform.'
Time Warner upgraded to 'buy,' Zynga initiated with a 'hold.'
Oil slips after a surprise rise in crude inventories. Second-quarter growth is revised up, but the pace remains slow. Pending home sales climb. The Fed's Beige Book is also on tap. WellPoint rises after its CEO resigns.
Eli Lilly is upgraded to 'overweight,' and GlaxoSmithKline is downgraded to 'neutral.'
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Joe Cantrell says he faces charges after trying to take advantage of the retailer's policy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.